Key Highlights
•
A new study found that adding the weight-loss drug tirzepatide to the arthritis medication ixekizumab led to significantly better disease control for patients with psoriatic arthritis who are overweight or obese, compared to using ixekizumab alone. This combination approach tackles both the inflammation and the metabolic issues common in this condition, offering a more comprehensive treatment strategy.
Source →
•
Researchers discovered that a specific genetic deletion in the ABCA7 gene, which is a strong risk factor for Alzheimer’s disease in individuals of African ancestry, disrupts how brain cells handle fats and damages their energy-producing mitochondria. This finding provides a crucial biological explanation for why this genetic variant increases Alzheimer’s risk, pointing toward potential new targets for prevention or treatment.
Source →
•
A clinical trial on a nerve block for pain relief after hip surgery showed it only provided modest benefits in the recovery room, like slightly less opioid use and a shorter stay, but did not improve overall pain or recovery quality in the first 24 hours. This suggests the procedure should not be used routinely for this surgery, but might be helpful in specific cases to manage early recovery.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
